↓ Skip to main content

mTORC1 Activation in Osteoclasts Prevents Bone Loss in a Mouse Model of Osteoporosis

Overview of attention for article published in Frontiers in Pharmacology, June 2019
Altmetric Badge

About this Attention Score

  • Average Attention Score compared to outputs of the same age
  • Average Attention Score compared to outputs of the same age and source

Mentioned by

twitter
3 X users

Citations

dimensions_citation
27 Dimensions

Readers on

mendeley
25 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
mTORC1 Activation in Osteoclasts Prevents Bone Loss in a Mouse Model of Osteoporosis
Published in
Frontiers in Pharmacology, June 2019
DOI 10.3389/fphar.2019.00684
Pubmed ID
Authors

Manami Hiraiwa, Kakeru Ozaki, Takanori Yamada, Takashi Iezaki, Gyujin Park, Kazuya Fukasawa, Tetsuhiro Horie, Hikari Kamada, Kazuya Tokumura, Mei Motono, Katsuyuki Kaneda, Eiichi Hinoi

X Demographics

X Demographics

The data shown below were collected from the profiles of 3 X users who shared this research output. Click here to find out more about how the information was compiled.
As of 1 July 2024, you may notice a temporary increase in the numbers of X profiles with Unknown location. Click here to learn more.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 25 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 25 100%

Demographic breakdown

Readers by professional status Count As %
Student > Ph. D. Student 6 24%
Student > Master 3 12%
Professor > Associate Professor 2 8%
Researcher 2 8%
Professor 1 4%
Other 2 8%
Unknown 9 36%
Readers by discipline Count As %
Medicine and Dentistry 8 32%
Biochemistry, Genetics and Molecular Biology 3 12%
Agricultural and Biological Sciences 1 4%
Unspecified 1 4%
Social Sciences 1 4%
Other 1 4%
Unknown 10 40%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 1. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 03 July 2019.
All research outputs
#15,576,397
of 23,151,828 outputs
Outputs from Frontiers in Pharmacology
#6,632
of 16,540 outputs
Outputs of similar age
#217,440
of 353,826 outputs
Outputs of similar age from Frontiers in Pharmacology
#195
of 344 outputs
Altmetric has tracked 23,151,828 research outputs across all sources so far. This one is in the 22nd percentile – i.e., 22% of other outputs scored the same or lower than it.
So far Altmetric has tracked 16,540 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 5.0. This one has gotten more attention than average, scoring higher than 55% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 353,826 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 30th percentile – i.e., 30% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 344 others from the same source and published within six weeks on either side of this one. This one is in the 38th percentile – i.e., 38% of its contemporaries scored the same or lower than it.